中源协和：关于全资子公司获得药物临床试验批准通知书的公告

Group 1 - The core point of the article is that Zhongyuan Union has received approval for clinical trials of VUM02 injection for the treatment of severe/critical pneumonia from the National Medical Products Administration [2] Group 2 - The approval was granted to Wuhan Guanggu Zhongyuan Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Zhongyuan Union [2] - The approval notification was issued on September 9, 2025 [2]